One of the more typical mutation types is the v‐raf murine sarcoma viral oncogene homolog B1 (BRAF) 600 amino acid substitution mutation from V to E (BRAFV600E), whose high‐frequency mutational properties are thought to be a factor associated with poor prognosis and overall survival in CRC [19]. This evidence concerns the gene BRAF and colorectal carcinoma.